Plasma pseudouridine levels reflect body size in children on hemodialysis

Frank J O'Brien1, Tammy L Sirich2, Abigail Taussig2

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Insights

Dialysis targeting urea reduction may lead to higher pseudouridine levels in smaller children. Measuring solutes proportional to body surface area may better assess dialysis adequacy in pediatrics.

Area of Science:

  • Pediatric Nephrology
  • Renal Replacement Therapy
  • Uremic Toxin Research

Background:

  • Standard dialysis prescription aims for a target spKt/Vurea, which may not adequately account for body surface area (BSA) differences in children.
  • Waste solute production can correlate more closely with BSA than urea distribution volume (Vurea), potentially leading to higher solute levels in smaller children.

Purpose of the Study:

  • To investigate whether dialysis prescribed to a target spKt/Vurea results in elevated plasma levels of pseudouridine (PU) in smaller pediatric patients.
  • To evaluate PU as a novel marker solute for dialysis adequacy, given its production is proportional to BSA.

Main Methods:

  • Measured plasma and dialysate levels of PU and urea nitrogen (ureaN) in 20 pediatric patients undergoing hemodialysis.
  • Utilized mathematical modeling to estimate solute production rates and average plasma solute levels.
  • Analyzed the relationship between patient size (BSA) and plasma solute levels.

Main Results:

  • Dialytic clearance of PU was proportional to that of ureaN.
  • PU production correlated significantly with BSA.
  • Pretreatment plasma PU levels were higher in smaller children, while ureaN levels did not vary with size.

Conclusions:

  • Current dialysis prescriptions based on urea kinetics may result in suboptimal uremic solute clearance in small children.
  • Measuring solutes like PU, which are produced proportionally to BSA, could offer a more accurate assessment of dialysis adequacy in pediatric populations.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
147
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
175
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
149
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
324
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
215
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
385